- 201. Immunoglobulin Light Chain, Lambda
- [Each antibody molecule is composed of two identical heavy chains and two identical light chains. Immunoglobulin Light Chain Lambda is one of two Ig light chain types. Lambda light chains are encoded by multiple V, J, and C gene segments, which are separated in the genome. During B cell development, a recombination event at the DNA level joins a single V segment with a J segment; the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. (from LocusLink, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0021037) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 251. immunoreactivity
- [ ] (UMLS (CSP) C0597879) =Molecular Function ;
|
- 202. immunoglobulin receptor
- [ ] (UMLS (CSP) C0597876) =Amino Acid, Peptide, or Protein; Receptor
| - 252. immunoregulatory alpha globulin
- [ ] (UMLS (CSP) C0082988) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 203. immunoglobulin registry
- [ ] (UMLS (CSP) C1331073) =Health Care Related Organization
| - 253. immunoscintigraphy
- [An imaging procedure in which antibodies labeled with radioactive substances are given to the person. A picture is taken of sites in the body where the antibody localizes. ( NCI )] (UMLS (NCI) C0085264) =Diagnostic Procedure ;
|
- 204. immunoglobulin resource
- [ ] (UMLS (CSP) C1331074) =Health Care Related Organization
| - 254. immunosenescence
- [age dependent decline in immune function. ( CSP )] (UMLS (CSP) C0596761) =Pathologic Function =immunopathology;
|
- 205. Immunoglobulin Switch Region
- [A site on a segment of a B-cell immunoglobulin heavy-chain gene where recombination (or rearrangement) can occur. It is involved in isotype or allotype switching and maturation of the immune response. Ig switch regions are found on genes encoding all five immunoglobulin heavy chains. ( NCI )] (UMLS (NCI) C0021021) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
| - 255. immunosuppression
- [natural, usually physiologic downregulation of the immune system; compare with ARTIFICIAL IMMUNOSUPPRESSION. ( CSP )] (UMLS (CSP) C0021080) =Organism Function ;
=immune tolerance/unresponsiveness;
|
- 206. Immunoglobulin Therapy
- (UMLS (NCI) C0021022) =Therapeutic or Preventive Procedure
| - 256. immunosuppressive alloantiserum
- [ ] (UMLS (CSP) C0596762) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 207. Immunoglobulin Variable Region
- [That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. ( MSH )] (UMLS (NCI) C0877857) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 257. immunosuppressive antileukocyte serum
- [equine antiserum against human lymphocytes, a powerful nonspecific immunosuppressive agent that causes destruction of circulating lymphocytes; also used as a histocompatability test. ( CSP )] (UMLS (CSP) C0178712) =Pharmacologic Substance; Immunologic Factor ;
=[IM400] IMMUNE SERUMS;
Immunologic Factors;
[IM600] IMMUNE SUPPRESSANTS;
|
- 208. immunohematology
- [branch of hematology which studies antigen-antibody reactions and analogous phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. ( CSP )] (UMLS (CSP) C0596754) =Biomedical Occupation or Discipline =Hematologic;
Immunology | - 258. Immunosuppressive Treatment Related Kaposi Sarcoma
- [A Kaposi sarcoma that develops after immunosuppressive treatment. ( NCI )] (UMLS (NCI) C0279085) =Neoplastic Process
|
- 209. Immunologic
- [branch of biomedical science concerned with the response of the organism to antigenic challenge, the recognition of self and foreign substances, and the biological, serological and physical chemical aspects of immune phenomena. ( CSP )] (UMLS (NCI) C0152036) =Biomedical Occupation or Discipline =Biologic;
=Ab;
antigen;
immunity;
immunogenetics;
neuroimmunomodulation;
psychoneuroimmunology;
immunophenotype;
host response;
developmental immunology;
fertility immunology;
immunohematology;
immunotoxicity;
microorganism immunology;
neoplasm/cancer immunology;
pregnancy immunology;
immune modulation | - 259. IMMUNOTHERAPY AS ANTINEO
- [ ] (UMLS (ICD9CM) C0376103) =Therapeutic or Preventive Procedure
|
- 210. immunologic assay
- [immunochemical assay or detection of a substance or immune response by serologic or immunologic methods. ( CSP )] (UMLS (CSP) C0519671) =Laboratory Procedure =immunologic technique;
=Blotting, Western;
ELISA;
histocompatibility typing;
Immunologic, Radioimmunoassay;
hypersensitivity test;
51 chromium release assay;
antibody titering;
immunoelectroadsorption;
serology/serodiagnosis | - 260. immunotoxicity
- [an adverse effect on the immune system or the reaction to a toxin by the immune system; includes reactions to agents that are not being used for immunotherapy, but some drugs or chemicals may have an unwanted immunosuppressive side effect. ( CSP )] (UMLS (CSP) C0596763) =Injury or Poisoning =Immunology;
|
- 211. immunologic preparation registry
- [ ] (UMLS (CSP) C1331075) =Health Care Related Organization
| - 261. immunotoxin
- [An antibody linked to a toxic substance. Some immunotoxins can bind to cancer cells and kill them. ( NCI )] (UMLS (NCI) C0021084) =Pharmacologic Substance; Immunologic Factor
|
- 212. immunologic preparation resource
- [ ] (UMLS (CSP) C1331076) =Health Care Related Organization
| - 262. immunotoxin (general)
- [ ] (UMLS (CSP) C0598672) =Hazardous or Poisonous Substance ;
|
- 213. immunologic substance development/preparation
- [preparation of naturally or artificially synthesized agents such as vaccines, toxins, toxoids, immune sera, antigens, antitoxins, antibodies, interleukins, cytokines, immunoglobulins, etc. ( CSP )] (UMLS (CSP) C0920678) =Laboratory Procedure ;
=technology/technique;
=vaccine development | - 263. immunotoxin (molecular hybrid)
- [ ] (UMLS (CSP) C0598657) =Immunologic Factor; Indicator, Reagent, or Diagnostic Aid ;
|
- 214. immunologic substance production
- [ ] (UMLS (CSP) C1328913) =Laboratory Procedure; ;
| - 264. Immunotoxin Therapy
- (UMLS (NCI) C0796507) =Therapeutic or Preventive Procedure
|
- 215. immunologic substance referral center
- [ ] (UMLS (CSP) C1331077) =Health Care Related Organization
| - 265. Immunotoxin, SS1(dsFv)-PE38
- [A recombinant immunotoxin consisting of the single chain anti-mesothelin monoclonal antibody SS1(dsFv) linked to Pseudomonas exotoxin PE-38. The monoclonal antibody moiety of the agent binds to cells that express mesothelin, a cell surface glycoprotein which may be overexpressed in ovarian cancer, mesotheliomas, and some squamous cell carcinomas; after internalization, the exotoxin moiety inactivates eukaryotic translation elongation factor 2, thereby disrupting tumor cell protein synthesis. (NCI04) ( NCI )] (UMLS (NCI) C1258770) SS1(dsFv) PE38;
SS1(dsFv)-PE38 Immunotoxin;
SS1P =Pharmacologic Substance; Immunologic Factor ;
|
- 216. immunologic substance registry
- [ ] (UMLS (CSP) C1331078) =Health Care Related Organization
| - 266. Imolamine
- (UMLS (NCI) C0063433) =Organic Chemical; Pharmacologic Substance
|
- 217. immunologic substance resource
- [ ] (UMLS (CSP) C1331079) =Health Care Related Organization
| - 267. IMP
- [purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. ( CSP )] (UMLS (CSP) C0021533) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=purine nucleotide;
|
- 218. immunologic substance resource/registry/referral center
- [facility or system for collection, storage, registration, record-keeping, and referral of immunologic data, materials, or resources, including antiserum, cytokines, allergens, interleukins, antibodies, etc.; includes preparations for the preservation of immunologic stocks and strains. ( CSP )] (UMLS (CSP) C1331064) =Health Care Related Organization =biomedical resource;
| - 268. IMP (Inosine Monophosphate) Dehydrogenase 1 Gene
- [This gene plays a role in the regulation of cell growth. ( NCI )] (UMLS (NCI) C1416427) IMPDH1;
IMPDH1 Gene;
=Gene or Genome |
- 219. immunologic technique
- [Laboratory technique involving interaction of antigens with specific antibodies. ( NCI )] (UMLS (CSP) C0021060) =Laboratory Procedure ;
=technology/technique;
=immunization;
Immunoelectrophoresis;
Anti-Rejection Therapy;
immunophenotype;
immunocytochemistry;
epitope mapping;
immunologic assay;
immunoaffinity chromatography;
| - 269. IMP (Inosine Monophosphate) Dehydrogenase 2 Gene
- [This gene is involved in the regulation of cell growth. ( NCI )] (UMLS (NCI) C1416428) IMPDH2;
IMPDH2 Gene;
=Gene or Genome |
- 220. immunologic test
- [Immunologic techniques involved in diagnosis. ( MSH )] (UMLS (CSP) C0021061) =Diagnostic Procedure ;
| - 270. IMP CARDIOMYOSTIMUL SYS
- [ ] (UMLS (ICD9CM) C0795775) Implantation of cardiomyostimulation system =Therapeutic or Preventive Procedure ;
|
- 221. Immunologic, Luciferase
- [An enzyme first isolated from firefly tails that catalyzes the production of light in the reaction between luciferin and ATP. ( NCI )] (UMLS (NCI) C0024075) =Amino Acid, Peptide, or Protein; Enzyme; Indicator, Reagent, or Diagnostic Aid
| - 271. IMP Dehydrogenase 1
- [Expressed as 2 alternative isoforms by human IMPDH1 Gene (IMPDH/GMPR Family), conserved homotetrameric IMP Dehydrogenase 1 is the rate-limiting enzyme in de novo guanine nucleotide synthesis and contains 2 CBS domains. Positioned at the branch point in adenine/guanine purine de novo synthesis, IMPDH1 catalyzes formation of xanthine monophosphate (XMP) from IMP, the first step in GMP biosynthesis from IMP. Involved in regulation of cell proliferation, inhibition of IMPDH1 activity blocks DNA synthesis and the cell cycle at the G1-S interface. IMPDH1 defects cause RP10. (NCI) ( NCI )] (UMLS (NCI) C1454821) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 222. Immunologic, Radioimmunoassay
- [quantitative chemical test based on displacement of radioligand from antigen-antibody complex; usually the radioligand and unknown are antigens; antibody specificity permits use of crude samples and antisera. ( CSP )] (UMLS (NCI) C0034580) =Laboratory Procedure ;
=immunologic assay;
ObservationMethod | - 272. IMP EXT HRT ASSIST SYST
- [ ] (UMLS (ICD9CM) C1456073) Implant of external heart assist system;
=Therapeutic or Preventive Procedure |
- 223. Immunological Diagnostic Method
- [Method used to identify disease using laboratory techniques involving interaction of antigens with specific antibodies. ( NCI )] (UMLS (NCI) C0677746) =Diagnostic Procedure ;
| - 273. IMP LIMB LENGTH KINETIC
- [ ] (UMLS (ICD9CM) C1455908) Implantation of internal limb lengthening device with kinetic distraction;
=Therapeutic or Preventive Procedure |
- 224. immunological diversity
- [ ] (UMLS (CSP) C0678890) =Organ or Tissue Function ;
| - 274. IMP/REP CRT DEFIB GENAT
- [ ] (UMLS (ICD9CM) C1135450) Implantation or replacement of cardiac resynchronization defibrillator pulse generator device only [CRT-D] =Therapeutic or Preventive Procedure
|
- 225. immunological status
- [ ] (UMLS (CSP) C0599818) =Laboratory Procedure ;
| - 275. IMP/REP CRT PACEMAKR GEN
- [ ] (UMLS (ICD9CM) C1135449) Implantation or replacement of cardiac resynchronization pacemaker pulse generator only [CRT-P] =Therapeutic or Preventive Procedure
|
- 226. immunological synapse
- [An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated lipid rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction. [GOC:mgi_curators, PMID:11244041, PMID:11376300] ( GO )] (UMLS (CSP) C1171348) =Cell Component ;
| - 276. IMP/REP LEAD LF VEN SYS
- [ ] (UMLS (ICD9CM) C1135448) Implantation or replacement of transvenous lead [electrode] into left ventricular coronary venous system =Therapeutic or Preventive Procedure
|
- 227. Immunologically Directed Therapy
- [use of immunologic agents to therapeutically enhance or suppress the immune system; includes immunization, vaccines, artificial immunosuppression, treatment with cytokines or immunoconjugates, and lymphocyte deletion therapy; in addition also index the specific disorder therapy and immunologic agent used. ( CSP )] (UMLS (NCI) C0021083) =Therapeutic or Preventive Procedure ;
=Therapeutic Interventions;
=immunization;
Anti-Rejection Therapy;
neoplasm/cancer immunotherapy | - 277. IMP/REP MCHAN COCHL PROS
- (UMLS (ICD9CM) C0176349) =Therapeutic or Preventive Procedure
|
- 228. Immunologist
- [A specialist in the science of immunology. ( NCI )] (UMLS (NCI) C0175808) =Professional or Occupational Group ;
| - 278. IMP/REP SCHAN COCH PROS
- (UMLS (ICD9CM) C0176348) =Therapeutic or Preventive Procedure
|
- 229. Immunology
- (UMLS (HL7) C1547987) =Intellectual Product =Diagnostic Service Section ID;
| - 279. IMP/REP SUBCUE CARD DEV
- [ ] (UMLS (ICD9CM) C1719281) Implantation or replacement of subcutaneous device for intracardiac hemodynamic monitoring =Therapeutic or Preventive Procedure
|
- 230. Immunology
- (UMLS (HL7) C1552393) =Professional or Occupational Group =Specialist/Technologist, Pathology;
| - 280. IMP/REPL BRAIN STIM LEAD
- [ ] (UMLS (ICD9CM) C0394158) =Therapeutic or Preventive Procedure
|
- 231. immunomagnetic bead technique
- [cell separation technique; used clinically in bone marrow purging; may possibly become a critical tool in food inspection serving as a prototype for a diagnostic assay in detecting microbial contaminants in food. ( CSP )] (UMLS (CSP) C0206618) =Laboratory Procedure; Research Activity =cell separation;
| - 281. IMP/REPL PERI STIM LEAD
- [ ] (UMLS (ICD9CM) C1456244) Implantation or replacement of peripheral neurostimulator lead(s);
=Therapeutic or Preventive Procedure ;
|
- 232. immunomodulator
- [agents of both drug and biological origin often used in immunotherapy to stimulate, potentiate, or depress the immune response; also used to inhibit or enhance specific subclasses of immunocytes. ( CSP )] (UMLS (CSP) C1527392) =Pharmacologic Substance; Immunologic Factor =Drug;
=Complete Freund's Adjuvant;
[IM600] IMMUNE SUPPRESSANTS;
1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid;
interferon inducer | - 282. IMP/REPL SPINE STIM LEAD
- [ ] (UMLS (ICD9CM) C1456238) Implantation or replacement of spinal neurostimulator lead(s);
=Therapeutic or Preventive Procedure ;
|
- 233. immunoneurology
- [A subdiscipline of immunology with a focus on the nervous system and its interactions with the immune system. ( NCI )] (UMLS (CSP) C0598946) =Organism Function
| - 283. IMP:pyrophosphate phosphoribosyltransferase deficiency
- [ ] (UMLS (CSP) C0677627) =Pathologic Function
|
- 234. immunopathology
- [diseases or abnormal states of the immune system. ( CSP )] (UMLS (CSP) C1609432) =Disease or Syndrome =Disease;
=autoimmune disease;
blood group incompatibility;
autoimmune foreign transplant disease;
Allergic Reaction;
hypoimmunity;
mast cell hyperplasia;
Besnier Boeck disease;
immune tolerance/unresponsiveness;
immunosenescence;
| - 284. Impact
- (UMLS (NCI) C0726639) =Food ;
|
- 235. Immunopathology
- (UMLS (HL7) C1555821) =Intellectual Product =pathologist;
| - 285. IMPACTED CERUMEN
- (UMLS (ICD9CM) C0021092) =Acquired Abnormality ;
|
- 236. immunopathology chemotherapy
- [application of the beneficial effects of drugs to control or cure diseases or abnormal states of the immune system. ( CSP )] (UMLS (CSP) C0596757) =Therapeutic or Preventive Procedure =chemotherapy;
immunopathology therapy | - 286. IMPACTED FECES REMOVAL
- [ ] (UMLS (ICD9CM) C0199901) =Therapeutic or Preventive Procedure
|
- 237. immunopathology diagnosis
- [determination of the presence of disease(s) or abnormal state of the immune system or the distinguishing of one disease or condition from another based on symptoms, medical history, risk factors, and clinical tests. ( CSP )] (UMLS (CSP) C0596758) =Diagnostic Procedure =Diagnosed;
=AIDS/HIV diagnosis;
| - 287. IMPACTION INTESTINE NEC
- [ ] (UMLS (ICD9CM) C0029640) =Disease or Syndrome
|
- 238. immunopathology therapy
- [refers to any type of treatment for an immunological disorder or disease. ( CSP )] (UMLS (CSP) C0596759) =Therapeutic or Preventive Procedure =Therapeutic Interventions;
=AIDS therapy;
immunopathology chemotherapy | - 288. IMPACTION INTESTINE NOS
- [ ] (UMLS (ICD9CM) C0392503) =Disease or Syndrome ;
|
- 239. immunoperoxidase
- [immunocytochemical methods using antibody coupled to the enzyme peroxidase to stain tissue constituents. ( CSP )] (UMLS (CSP) C0021067) =Laboratory Procedure ;
=immunocytochemistry;
| - 289. IMPAIR REN FUNCT DIS NEC
- [ ] (UMLS (ICD9CM) C0029791) =Disease or Syndrome ;
|
- 240. Immunoperoxidase, Avidin-Biotin Complex
- [Immune stain, Immunoperoxidase, Avidin-Biotin Complex ( HL7V3.0 )] (UMLS (HL7) C0200822) =Laboratory Procedure =ObservationMethod;
| - 290. Impaired
- [Loss or abnormality of psychological, physiological, or anatomic structure or function. ( NCI )] (UMLS (NCI) C0684336) =Finding
|
- 241. Immunoperoxidase, Peroxidase anti-peroxidase complex
- [Immune stain, Immunoperoxidase, Peroxidase anti-peroxidase complex ( HL7V3.0 )] (UMLS (HL7) C1553149) =Laboratory Procedure =ObservationMethod;
| - 291. IMPAIRED FASTING GLUCOSE
- (UMLS (ICD9CM) C1272092) =Finding; ;
|
- 242. Immunoperoxidase, Protein A-peroxidase complex
- [Immune stain, Immunoperoxidase, Protein A-peroxidase complex ( HL7V3.0 )] (UMLS (HL7) C1553150) =Laboratory Procedure =ObservationMethod;
| - 292. Impaired glucose tolerance test (oral)
- [ ] (UMLS (ICD9CM) C1260441) IMPAIRED ORAL GLUCSE TOL =Finding
|
- 243. immunopharmacology
- [study of the origin, nature, properties, and actions of drugs and their effects on the immune system but not necessarily specifically immunotherapy; use this term mainly for intended, desired effects. ( CSP )] (UMLS (CSP) C0681953) =Biomedical Occupation or Discipline =Pharmacologic;
| - 293. Impaired Renal Function
- (UMLS (NCI) C0341697) =Disease or Syndrome
|
- 244. immunophenotype
- [Immunophenotype is the characterization of a set of cells according to the antigens expressed. ( NCI )] (UMLS (CSP) C0079611) =Laboratory Procedure ;
=immunologic technique;
Immunology | - 294. IMPAIRM AUDITORY DISCRIM
- [ ] (UMLS (ICD9CM) C0155537) =Finding
|
- 245. Immunoprotein
- [A complex consisting of an immune component and a protein. This complex molecule modulates a variety of activities that are regulated by the immune system. ( NCI )] (UMLS (NCI) C0021072) =Amino Acid, Peptide, or Protein; Immunologic Factor =blood protein;
=[IM500] IMMUNOGLOBULINS | - 295. Impairment evaluation center
- [Focuses on assessing disability ( HL7V3.0 )] (UMLS (HL7) C1552781) =Intellectual Product =Outpatient facility;
|
- 246. Immunoprotein Gene
- [Immunoprotein Genes encode proteins whose activities affect or play a role in immune system functions. ( NCI )] (UMLS (NCI) C1334166) =Gene or Genome ;
| - 296. IMPEDANCE PHLEBOGRAM
- [ ] (UMLS (ICD9CM) C0202952) =Diagnostic Procedure
|
- 247. immunopsychiatry
- [ ] (UMLS (CSP) C0599243) =Biomedical Occupation or Discipline ;
| - 297. IMPERFORATE HYMEN
- (UMLS (ICD9CM) C0152436) =Congenital Abnormality ;
|
- 248. Immunoradiometric assay (IRMA)
- [Immunoassay, Immunoradiometric Assay ( HL7V3.0 )] (UMLS (HL7) C0021073) =Laboratory Procedure ;
=ObservationMethod;
| - 298. Impetigo
- [A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.(MSH)] (UMLS (ICPC) C0021099) (Impetigo; INPETIGOA; Impetigo; Impetigo; MARKARUPI; Impetigo; Impetigo; impetigo; impetigo; Impetigine; BRENNKOPPER; Impetigo; Impetigo; IMPETIGO) =Disease or Syndrome ;
=Staphylococcal Skin Infections; Streptococcal Infections; Diagnosis/Diseases Component; Integument |
- 249. Immunoradiotherapy
- [Treatment with a radioactive substance that is linked to an antibody that will attach to the tumor when injected into the body. ( NCI )] (UMLS (NCI) C0085101) =Therapeutic or Preventive Procedure ;
| - 299. IMPETIGO HERPETIFORMIS
- (UMLS (ICD9CM) C1314968) =Disease or Syndrome; ;
|
- 250. immunoreaction
- [ ] (UMLS (CSP) C0872193) =Organism Function ;
| - 300. IMPL CARDIAC SUPPORT DEV
- [ ] (UMLS (ICD9CM) C1561895) Implantation of prosthetic cardiac support device around the heart;
=Therapeutic or Preventive Procedure |
home
